6,495 Shares in Humana Inc. $HUM Acquired by United Capital Financial Advisors LLC

United Capital Financial Advisors LLC bought a new position in shares of Humana Inc. (NYSE:HUM) in the second quarter, Holdings Channel reports. The firm bought 6,495 shares of the insurance provider’s stock, valued at approximately $2,580,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Johnson Financial Group Inc. bought a new position in shares of Humana in the second quarter valued at approximately $26,000. Trust Co. of Vermont bought a new stake in shares of Humana during the 2nd quarter worth $28,000. Bogart Wealth LLC grew its stake in Humana by 192.0% in the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares during the last quarter. MidFirst Bank bought a new position in Humana in the 2nd quarter worth $35,000. Finally, Montag A & Associates Inc. raised its holdings in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Lake Street Capital started coverage on shares of Humana in a report on Thursday, July 30th. They set a “buy” rating for the company. Leerink Partners upgraded Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective on the stock in a research note on Thursday, July 30th. Robert W. Baird set a $390.00 price objective on Humana in a research report on Thursday, July 30th. JPMorgan Chase & Co. increased their target price on Humana from $316.00 to $393.00 and gave the company a “neutral” rating in a research note on Monday, August 10th. Finally, Wells Fargo & Company raised Humana from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $227.00 to $502.00 in a research report on Monday, July 13th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and an average price target of $403.91.

Humana Trading Down 1.5%

Shares of HUM opened at $386.92 on Friday. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $46.46 billion, a price-to-earnings ratio of 36.61, a P/E/G ratio of 2.24 and a beta of 0.72. The stock’s 50-day moving average price is $385.60 and its 200 day moving average price is $288.47.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter last year, the company earned $6.27 EPS. The company’s quarterly revenue was up 26.2% on a year-over-year basis. As a group, research analysts predict that Humana Inc. will post 9.12 earnings per share for the current year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.